Physician

Firas Kassab, M.D.

According to 2025 Medicare claims, Firas Kassab, M.D. (NPI: 1366649014) practices rheumatology in the Charlotte-Concord-Gastonia, NC-SC market, with the plurality of this provider's patient population coming from York, SC. This provider's primary affiliated billing organization is SOUTH CHARLOTTE RHEUMATOLOGY, PLLC (NPI: 1598410565; TIN: 874539779) and primary practice location at 28277-6806.

Kassab's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 337 traditional Medicare patients, billed 166,155 HCPCS/CPT codes, and received $1,602,829 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,331 prescription claims across 285 beneficiaries totaling $680,199 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 93 records totaling $7,040. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $960,986 to $1,602,829. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	710	67,156	$960,986
2016	708	61,774	$960,825
2017	689	50,201	$1,186,793
2018	368	56,820	$1,192,740
2019	446	88,240	$1,554,072
2020	454	99,470	$1,618,467
2021	234	98,696	$1,308,754
2022	278	135,116	$1,870,720
2023	306	140,028	$2,121,403
2024	337	166,155	$1,602,829

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	241	1,778	$587,989
2016	266	1,942	$603,287
2017	297	2,281	$1,091,376
2018	315	2,032	$962,569
2019	311	2,171	$1,023,870
2020	259	1,816	$867,310
2021	225	1,474	$748,308
2022	251	1,712	$930,232
2023	252	1,584	$922,242
2024	285	1,331	$680,199

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	72	370	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	253	510	$92
J0897	Injection, denosumab, 1 mg	81	7,920	$21
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	197	310	$13
96372	Injection of drug or substance under skin or into muscle	98	200	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	19	532	$147,036
Benlysta	Belimumab	26	728	$121,851
Actemra Actpen	Tocilizumab	12	392	$69,166
Tymlos	Abaloparatide	12	360	$29,921
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	183	12,466	$5,390

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	93	$7,040	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Firas Kassab, M.D.?

Tedicare shows public-source Medicare data for Firas Kassab, M.D. (NPI 1366649014), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Firas Kassab, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Firas Kassab, M.D.?

Firas Kassab, M.D. is linked to SOUTH CHARLOTTE RHEUMATOLOGY, PLLC (billing NPI 1598410565) in the available physician profile data.

Does Firas Kassab, M.D. have Open Payments data?

Firas Kassab, M.D. has 93 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.